Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2003
11/12/2003EP1359930A2 Novisprins: antimicrobial peptides
11/12/2003EP1359927A1 Herbal pharmaceutical compositions for treating immunological disorders
11/12/2003EP1359923A1 Use of selenite or preparations containing selenite for treating wounds
11/12/2003EP1359901A2 Thermolabile liposome with controlled release temperature
11/12/2003EP1359900A1 A stable pharmaceutical formulation comprising torsemide modification ii
11/12/2003EP1359899A1 Composition and method for controlled release injections
11/12/2003EP1359884A2 Cosmetic and/or pharmaceutical agent comprising acylated amino acids
11/12/2003EP1359883A2 (psi)(epsilon)rack peptide composition and method for protection against tissue damage due to ischemia
11/12/2003EP1255557B1 Stable, nasally, orally or sublingually applicable pharmaceutical preparation containing desmopressin
11/12/2003EP1246830B1 Macrocyclic chelants for metallopharmaceuticals
11/12/2003EP1229909B1 Transdermal delivery of lasofoxifene
11/12/2003EP1216057B1 Stable calcitriol solution for packaging in vials
11/12/2003EP1137400B1 Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period toff, verfahren zu seiner herstellung und anlage zur durchfuhrung des verfahrens
11/12/2003EP1069886B1 Use of a topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, for providing a prolonged effect of an incorporated active substance
11/12/2003EP1032390B1 Anaesthetic formulation
11/12/2003EP0986403B1 Composition with extended shelf-life storage comprising cyclodextrin and drugs or prodrugs that decompose to water-insoluble components
11/12/2003EP0944383B1 Pharmaceutical suspension systems
11/12/2003EP0817650B1 Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
11/12/2003EP0804163B1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof
11/12/2003EP0745382B1 Intraorally soluble compressed molding and process for producing the same
11/12/2003EP0583378B1 Combined calcium and vitamin d supplements
11/12/2003CN1455691A Pharmaceutical compositions
11/12/2003CN1455678A Methods of therapy with thrombin derived peptides
11/12/2003CN1455669A Esmolol formulation
11/12/2003CN1455666A Externally-applicated chewing gum including chip-like center
11/12/2003CN1455665A Medicinal composition
11/12/2003CN1455663A Novel aerosol formulation containing polar fluorinated molecule
11/12/2003CN1455662A Dental care compositions
11/12/2003CN1454903A Technique of producing dextrin for pharmacy
11/12/2003CN1454602A High water-soluble povidone-iodine cream
11/12/2003CN1127477C Methods and compositions for lipidization of hydrophilic molecules
11/12/2003CN1127350C Cyclosorin-containing soft capsule preparations
11/12/2003CN1127340C Composition containing nicotine compound, use thereof and its formation method
11/12/2003CN1127334C Water-soluble or water-dispersible polyurethanes coatings or binders for medicine coating
11/12/2003CN1127333C Local pharmaceutical composition comprising cholinergic agent or calcium channel blocker
11/11/2003US6646162 Compounds and compositions for delivering active agents
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6646110 G-CSF polypeptides and conjugates
11/11/2003US6646014 Organic compounds
11/11/2003US6646007 Process for preparing a pharmaceutical formulation containing levothyroxine sodium
11/11/2003US6645988 Pharmaceutical preparations comprising substituted benzimidazole proton pump inhibitors with fast acting buffer; gastric acid stability for enteral administration
11/11/2003US6645963 Prolonged-action eye drop
11/11/2003US6645946 Delivery of a therapeutic agent in a formulation for reduced toxicity
11/11/2003US6645942 Implanting collagen matrix containing transduced subject-derived primary fibroblasts infected with recombinant retroviral vector; gene expression
11/11/2003US6645532 Compositions and method for relieving discomfort in the ears
11/11/2003US6645531 Halting, diminishing, or inhibiting the growth of at least one of a bacterium, a fungus; a parasitic microbe, and a virus, which method comprises administering at least one electron active compound
11/11/2003US6645529 Soluble coatings; variations in bulk density
11/11/2003US6645527 Stabilized sustained release tramadol formulations
11/11/2003US6645523 Paroxetine compositions and processes for making the same
11/11/2003US6645522 Erythropoietin or derivatives that cause bone marrow cells to increase production of reticulocytes and erythrocytes; hydrogenated lecithin that may be hydrogenated; cholesterol or a derivative; phosphate buffer
11/11/2003US6645520 Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
11/11/2003US6645517 Which absorbs electromagnetic radiation, and uses the energy to trigger drug delivery; for multiples injections; diabetes
11/11/2003US6645516 Hydrosoluble composition comprising lipophilic vegetable material and at least two ecologically optimized surfactants
11/11/2003US6645508 Stabilized with N-methyl-2-pyrrolidone; topical composition stable for up to 2 months
11/11/2003US6645506 Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
11/11/2003US6645495 Compositions of saponin adjuvants and excipients
11/11/2003US6645494 An antibody, or a binding fragment thereof, specific for human CD40L antigen conjugated to a Type I ribosome inactivating protein
11/11/2003US6645484 Endothelial cell transmembrane tyrosine kinase ligand
11/11/2003US6645476 Preparable by free-radical copolymerization of macromonomers containing an end-group capable of polymerization, a hydrophilic moiety based on polyalkylene oxides, and a hydrophobic moiety with olefincally unsaturated comonomers
11/11/2003US6645466 Dry powder for inhalation
11/11/2003US6645464 Loading metal particles into cell membrane vesicles and metal particular use for imaging and therapy
11/06/2003WO2003091398A2 Compositions and methods for stem cell delivery
11/06/2003WO2003091387A2 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands
11/06/2003WO2003091299A1 Hydrophilic polymers and methods of preparation
11/06/2003WO2003091290A1 Method for reduction of residual organic solvent in carbomer
11/06/2003WO2003091283A1 Gelatin derivatives and high-molecular micelles comprising the same
11/06/2003WO2003090818A2 Drug-delivery endovascular stent and method for treating restenosis
11/06/2003WO2003090805A1 Process for production of hydrogel material enhanced in the intake of drugs and permitting sustained release of drugs
11/06/2003WO2003090800A1 Wound dressings comprising hydrated hydrogels and enzymes
11/06/2003WO2003090787A1 Synthetic anti-candida albicans oligosaccharide based vaccines
11/06/2003WO2003090781A1 Methods and devices for targeting a site in a mammal and for removing species from a mammal
11/06/2003WO2003090767A1 An injection made from ixeris sonchifolia for treatment of cardio-cerebral vascular disease and fundus diseases and method of producing thereof
11/06/2003WO2003090763A1 Composition and kit for the treatment of inflammatory bowel diseases
11/06/2003WO2003090744A1 Antibacterial compositions comprising metal phthalocyanine analogues
11/06/2003WO2003090729A1 Transdermal analgesic systems with reduced abuse potential
11/06/2003WO2003090728A1 Use of a mare's milk concentrate dried on a highly-dispersed, biologically inert matrix
11/06/2003WO2003090727A1 Colloidal suspension of submicronic particles for delivering active principles and method for preparing same
11/06/2003WO2003090726A2 Chewable soft capsule
11/06/2003WO2003090725A1 Capsule preparation
11/06/2003WO2003090724A1 Coated particles with prolonged release and tablets containing same
11/06/2003WO2003090723A1 Modified-release vasopeptidase inhibitor formulation, combinations and method
11/06/2003WO2003090722A2 Microparticle pharmaceutical compositions for intratumoral delivery
11/06/2003WO2003090720A1 High drug load tablet
11/06/2003WO2003090719A1 Histidine copolymer and methods for using same
11/06/2003WO2003090712A2 Compositions for treating hyperemia
11/06/2003WO2003090710A1 Lapachone delivery systems, compositions and uses related thereto
11/06/2003WO2003090703A1 Oral care products containing ovomucin
11/06/2003WO2003090697A2 Chimeric hybrid analgesics
11/06/2003WO2003090684A2 Polymer compositions containing a macrocyclic triene compound
11/06/2003WO2003090682A2 Treatment and prevention of pulmonary conditions
11/06/2003WO2003090662A2 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
11/06/2003WO2003090640A2 Microbial cellulose wound dressing for treating chronic wounds
11/06/2003WO2003079981A3 Bioadhesive drug delivery system
11/06/2003WO2003075685A3 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
11/06/2003WO2003072711A3 Method of using modified oligonucleotides for hepatic delivery
11/06/2003WO2003072705A3 Rna interference mediated inhibition of cyclin d1 gene expression using short interfering nucleic acid (sina)
11/06/2003WO2003072025A3 Modified release formulations of at least one form of tramadol
11/06/2003WO2003062198A8 Integrin targeted imaging agents
11/06/2003WO2003049637A3 In situ bonds
11/06/2003WO2003034975A3 Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
1 ... 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 ... 1712